Many studies have suggested that genetic polymorphisms in the epidermal growth factor receptor (EGFR) are associated with risk of glioma [5–7], breast cancer [8], colorectal adenoma and colorectal cancer [9], and non-small cell lung cancer [10]. The gene discussed is EGFR; the disease is colorectal adenoma.